Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4305-4309

  Aikawa, Hirokazu ^a   Takahashi, Hiroto ^a   Fujimura, Shigefumi ^a   Sato, Masami ^a   Endo, Chiaki ^a   Sakurada, Akira ^a   Kondo, Takashi ^a   Tanita, Tatsuo ^a   Matsumura, Yuji ^a   Ono, Sadafumi ^a   Saito, Yasuki ^a   Sagawa, Motoyasu ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Lung cancer; Microvessel density; PD ECGF; VEGF

Indexed keywords

ANGIOGENIC FACTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0032762668     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
2. Folkman J: Angiogenesis in cancer,vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995.
3. Ferrara N and Henzel W: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-859, 1989.
4. Leug D, Cachianes G, Kuang W, Goeddel D and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
5. Asano M, Yukita A, Matsumoto T, Kondo S and Suzuki H: Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. Cancer Res 55: 5296-5301, 1995.
6. Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994.
7. Kieser A, Weich H, Brandner G, Marme D and Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994.
8. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Heldin C: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989.
9. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K and Akiyama S: Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1034: 107-113, 1990.
10. Takehayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, Okumura H, Yamada Y, Akiyama S and Aikou T: The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 32A: 1227-1232, 1996.
11. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishizawa M, Yamada Y and Akiyama S: Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem 114: 9-14, 1993.
12. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Caccer (PredOncol) 64: 79-82, 1995.
13. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T and Aikou T: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87: 288-295, 1996.
14. Maeda K, Chung Y, Ogawa Y, Takatsuka S, Kang S, Ogawa M, Sawada T, Onoda N, Kato Y and Sowa M: Thymidine phosphorylase/ platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884-888, 1996.
15. Mattern J, Koomagi R and Volm M: Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73: 931-934, 1996.
16. Koukourakis sM, Giatromanolaki A, O'Byrne K, Comley M, Whitehouse R, Talbot D, Gatter K and Harris A: Platelet-derived endothelial cell growth factor expression correlates with tumour angiogeneis and prognosis in non-small-cell lung cancer. Br J Cancer 75: 477-481, 1997.
17. Volm M, Koomagi R and Mattern J: Interrelationships between microvessel density, expression of VEGF and resistance to doxoruhicin of non-small cell lung carcinoma. Anticancer Res 16: 213-218, 1996.
18. Volm M, Koomagi R and Mattern J: Prognotic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Caccer (PredOncol) 74: 64-68, 1997.
19. Weidner N, Semple J, Welch W and Folkman J: Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
20. WHO: Histological typing of lung tumours. 2nd ed. Geneva, WHO, 1981, pp 22-28.
21. UICC: TNM classification of malignant tumours. 5th ed. New York, Wiley-Liss, 1997, pp 93-97.
22. Inoue K, Ozeki Y, Suganuma T, Sugiura Y and Tanaka S: Vascular endothelial growth factor expression in primary esophageal squamus cell carcinoma. Cancer 79: 206-213, 1997.
23. Giatromanolaki SA, Koukourakis M, Comley M, Kaklamanis L, Turley H, O'Byrne K, Harris A and Gatter K: Platelet-derived endothelial cell growth factor expression correlates with tumour angiogeneis and prognosis in non-small-cell lung cancer (thymidine phosphorylase) expression in lung cancer. J Pathol 181: 196-199, 1997.
24. Ohta Y, Watanabe Y, Murakami S, Oda M, Hayashi Y, Nonomura A, Endo Y and Sasaki T: Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Br J Cancer 76: 1041-1045, 1997.
25. Macchiarini P, Fontanini G, Hardin M. Squartini F and Angeletti C: Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340: 145-146, 1992.
26. Yuan A, Yang P, Yu C, Lee Y, Yao Y, Chen C, Lee L, Kuo S and Luh K: Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med 152: 2157-2162, 1995.
27. Fontanini G, Vignati S, Lucchi M, Mussi A, Calcinai A, Boldrini L, Chine S, Silvestri V, Angeletti C, Basolo F and Bevilacqua G: Neoangiogenesis and p53 protein in lung cancer : their prognotic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer 75: 1295-1301, 1997.
28. Takanami I, Tanaka F, Hashizume T and Kodaira S: Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res 17: 2811-2814, 1997.
29. Yamazaki K, Abe S, Takekawa H, Sukoh N, Watanahe N, Ogura S, Nakajima I, Isobe H, Inoue K and Kawakami Y: Tumor angiogenesis in human lung adenocarcinoma. Cancer 74: 2245-2250, 1994.
30. Harpole D, Richards W, II JH and Sugarbaker D: Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg 61: 1470-1476, 1996.